SCHEMBL845059

SCHEMBL845059

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cccnc3Sc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1cccnc1Sc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TRPV1 Q8NER1 1/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
PABPC1 P11940 1/20 0.42
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
DGAT1 O75907 2/20 0.40
ATM Q13315 1/20 0.39
EP300 Q09472 1/20 0.39
CREBBP Q92793 1/20 0.39
HCRTR1 O43613 2/20 0.39
HCRTR2 O43614 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845710 0.88 KMT2A (0.43) ALDH1A1TRPV1CYP2C9CYP2C19PABPC1
SCHEMBL846011 0.85 TRPV1 (0.42) ALDH1A1TRPV1CYP2C9CYP2C19PABPC1
SCHEMBL844980 0.83 ALDH1A1 (0.45) ALDH1A1TRPV1CYP2C9CYP2C19PABPC1
SCHEMBL845708 0.83 RHOC (0.46) ALDH1A1TRPV1CYP2C9CYP2C19SMN1; SMN2
SCHEMBL845048 0.81 DGAT1 (0.50) ALDH1A1CYP2C9CYP2C19SMN1; SMN2PABPC1
SCHEMBL845651 0.81 CYP2C9 (0.43) ALDH1A1TRPV1CYP2C9CYP2C19PABPC1
SCHEMBL845686 0.81 HSD11B1 (0.43) ALDH1A1TRPV1CYP2C9CYP2C19SMN1; SMN2
SCHEMBL845704 0.80 TRPV1 (0.48) ALDH1A1TRPV1CYP2C9CYP2C19PABPC1
SCHEMBL845008 0.79 ALDH1A1 (0.54) ALDH1A1CYP2C9CYP2C19MAPK1HTT
SCHEMBL845301 0.79 PABPC1 (0.51) ALDH1A1TRPV1CYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed